Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies
Not Applicable
- Conditions
- Cancer
- Interventions
- Procedure: Biopsy
- First Posted Date
- 2015-08-07
- Last Posted Date
- 2019-01-03
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 700
- Registration Number
- NCT02517281
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France
A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents
Not Applicable
Active, not recruiting
- Conditions
- Metastatic Oncogen-driven Cancer
- Interventions
- Procedure: Biopsy
- First Posted Date
- 2015-08-07
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 1500
- Registration Number
- NCT02517892
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France
A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers
- First Posted Date
- 2015-08-06
- Last Posted Date
- 2016-01-26
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Registration Number
- NCT02516774
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val de Marne, France
Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer
Not Applicable
Completed
- Conditions
- Prostate Cancer
- Interventions
- Device: Functional magnetic resonance imagingDevice: Ultrasound
- First Posted Date
- 2015-08-06
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 10
- Registration Number
- NCT02516995
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val de Marne, France
Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors
Not Applicable
Active, not recruiting
- Conditions
- Head and Neck Cancer
- Interventions
- Device: Transoral robotic-assisted surgery with Da Vinci Xi
- First Posted Date
- 2015-08-06
- Last Posted Date
- 2024-03-26
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 100
- Registration Number
- NCT02517125
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France
Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers
Phase 1
Completed
- Conditions
- Cervical Cancer
- Interventions
- First Posted Date
- 2015-08-05
- Last Posted Date
- 2016-06-09
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 15
- Registration Number
- NCT02515877
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val de Marne, France
Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases
Phase 2
Completed
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 104
- Registration Number
- NCT02494973
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France
Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents
Not Applicable
Completed
- Conditions
- Non-Hodgkin Lymphoma
- Interventions
- Device: PET / CT
- First Posted Date
- 2015-07-02
- Last Posted Date
- 2019-06-18
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 230
- Registration Number
- NCT02488369
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France
Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer
Phase 2
Completed
- Conditions
- Thyroid Cancer
- Interventions
- Radiation: Radium 223
- First Posted Date
- 2015-03-18
- Last Posted Date
- 2019-06-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 13
- Registration Number
- NCT02390934
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val De Marne, France
Transpulmonary Thermodilution Using an Implented Central Venous Access Port
Completed
- Conditions
- Medical Oncology
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2016-06-09
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 20
- Registration Number
- NCT02357953
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val de Marne, France
© Copyright 2025. All Rights Reserved by MedPath